Falling for six consecutive days, Aurora Cannabis ended the session at 56 cents (down 4.4%)

A quick look at Friday: the Canadian cannabis producer dropped 4.4% early on and traded close to the 56 cents level.

The MACD index is indicating that momentum is shifting from bullish to bearish following a negative crossover. When the MACD falls below the signal line, it is typically considered to be a bearish development favoring short positions. In contrast, Aurora Cannabis's lower Bollinger Band® is at 54.9501 cents, indicating that the asset has overextended to the downside and could, therefore, bounce back as buyers look for bargains. Aurora Cannabis could begin to recover as it approaches significant support, now 2 cents away from 54.3433 cents. Dipping below could be an indication that further losses are ahead.

Overall, looking at the technical analysis landscape, it seems that although indicators are mixed and some are pointing in different directions further drawbacks may be next for Aurora Cannabis.

Aurora Cannabis was not the only decliner in the health care sector; Bristol-Myers Squibb Company closed at $68.06 (down 1.48%). Thermo Fisher Scientific went down 0.97%, closed at $529.79.

On the other hand, positive performances could be seen by looking at other health care stocks as Novo Nordisk traded at $171.27 after closing Friday's trading day at $169 (up 1.35%).

The Canadian cannabis spearhead has recovered 4.61% since descending to a significant low of 56 cents around 2 days ago.